As of Jul 31
| +0.05 / +1.02%|
The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +41.70% increase from the last price of 4.94.
The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.